Altering the tropism of lentiviral vectors through pseudotyping
- PMID: 16101513
- PMCID: PMC1368960
- DOI: 10.2174/1566523054546224
Altering the tropism of lentiviral vectors through pseudotyping
Erratum in
- Curr Gene Ther. 2005 Oct;5(5):531
Abstract
The host range of retroviral vectors including lentiviral vectors can be expanded or altered by a process known as pseudotyping. Pseudotyped lentiviral vectors consist of vector particles bearing glycoproteins (GPs) derived from other enveloped viruses. Such particles possess the tropism of the virus from which the GP was derived. For example, to exploit the natural neural tropism of rabies virus, vectors designed to target the central nervous system have been pseudotyped using rabies virus-derived GPs. Among the first and still most widely used GPs for pseudotyping lentiviral vectors is the vesicular stomatitis virus GP (VSV-G), due to the very broad tropism and stability of the resulting pseudotypes. Pseudotypes involving VSV-G have become effectively the standard for evaluating the efficiency of other pseudotypes. This review samples a few of the more prominent examples from the ever-expanding list of published lentiviral pseudotypes, noting comparisons made with pseudotypes involving VSV-G in terms of titer, viral particle stability, toxicity, and host-cell specificity. Particular attention is paid to publications of successfully targeting a specific organ or cell types.
Similar articles
-
Lentiviral Vector Pseudotypes: Precious Tools to Improve Gene Modification of Hematopoietic Cells for Research and Gene Therapy.Viruses. 2020 Sep 11;12(9):1016. doi: 10.3390/v12091016. Viruses. 2020. PMID: 32933033 Free PMC article. Review.
-
Pseudotyped Lentiviral Vectors: One Vector, Many Guises.Hum Gene Ther Methods. 2017 Dec;28(6):291-301. doi: 10.1089/hgtb.2017.084. Epub 2017 Sep 4. Hum Gene Ther Methods. 2017. PMID: 28870117 Review.
-
Human immunodeficiency virus type 1-derived lentivirus vectors pseudotyped with envelope glycoproteins derived from Ross River virus and Semliki Forest virus.J Virol. 2004 Feb;78(3):1421-30. doi: 10.1128/jvi.78.3.1421-1430.2004. J Virol. 2004. PMID: 14722297 Free PMC article.
-
Transduction of bone-marrow-derived mesenchymal stem cells by using lentivirus vectors pseudotyped with modified RD114 envelope glycoproteins.J Virol. 2004 Feb;78(3):1219-29. doi: 10.1128/jvi.78.3.1219-1229.2004. J Virol. 2004. PMID: 14722277 Free PMC article.
-
Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range.J Virol. 2002 Feb;76(3):1488-95. doi: 10.1128/jvi.76.3.1488-1495.2002. J Virol. 2002. PMID: 11773421 Free PMC article.
Cited by
-
Multi-scale in vivo imaging of tumour development using a germline conditional triple-reporter system.Res Sq [Preprint]. 2024 Apr 3:rs.3.rs-4196140. doi: 10.21203/rs.3.rs-4196140/v1. Res Sq. 2024. PMID: 38645088 Free PMC article. Preprint.
-
Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma.Sci Rep. 2024 Mar 23;14(1):6958. doi: 10.1038/s41598-024-57286-6. Sci Rep. 2024. PMID: 38521856 Free PMC article.
-
Protection from cisplatin-induced hearing loss with lentiviral vector-mediated ectopic expression of the anti-apoptotic protein BCL-XL.Mol Ther Nucleic Acids. 2024 Feb 19;35(1):102157. doi: 10.1016/j.omtn.2024.102157. eCollection 2024 Mar 12. Mol Ther Nucleic Acids. 2024. PMID: 38450280 Free PMC article.
-
Targeted nonviral delivery of genome editors in vivo.Proc Natl Acad Sci U S A. 2024 Mar 12;121(11):e2307796121. doi: 10.1073/pnas.2307796121. Epub 2024 Mar 4. Proc Natl Acad Sci U S A. 2024. PMID: 38437567 Free PMC article. Review.
-
Generation of Viral Particles with Brain Cell-Specific Tropism by Pseudotyping HIV-1 with the Zika Virus E Protein.Methods Protoc. 2023 Dec 28;7(1):3. doi: 10.3390/mps7010003. Methods Protoc. 2023. PMID: 38251196 Free PMC article.
References
-
- Azzouz M, Ralph GS, Storkebaum E, Walmsley LE, Mitrophanous KA, Kingsman SM, Carmeliet P, Mazarakis ND. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature. 2004b;429:413–417. - PubMed
-
- Baekelandt V, Eggermont K, Michiels M, Nuttin B, Debyser Z. Optimized lentiviral vector production and purification procedure prevents immune response after transduction of mouse brain. Gene Ther. 2003;10:1933–1940. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources